Abstract:We report a case of partial diazoxide responsiveness in a child with severe congenital hyperinsulinaemic hypoglycaemia (CHI) due to a homozygous ABCC8 mutation. A term baby, with birth weight 3.8 kg, born to consanguineous parents presented on day 1 of life with hypoglycaemia. Hypoglycaemia screen confirmed CHI. Diazoxide was commenced on day 7 due to ongoing elevated glucose requirements (15 mg/kg/min), but despite escalation to a maximum dose (15 mg/kg/day), intravenous (i.v.) glucose requirement remained high (13 mg/kg/min). Genetic testing demonstrated a homozygous ABCC8 splicing mutation (c.2041-1G>C), consistent with a diffuse form of CHI. Diazoxide treatment was therefore stopped and subcutaneous (s.c.) octreotide infusion commenced. Despite this, s.c. glucagon and i.v. glucose were required to prevent hypoglycaemia. A trial of sirolimus and near-total pancreatectomy were considered, however due to the significant morbidity potentially associated with these, a further trial of diazoxide was commenced at 1.5 months of age. At a dose of 10 mg/kg/day of diazoxide and 40 µg/kg/day of octreotide, both i.v. glucose and s.c. glucagon were stopped as normoglycaemia was achieved. CHI due to homozygous ABCC8 mutation poses management difficulties if the somatostatin analogue octreotide is insufficient to prevent hypoglycaemia. Diazoxide unresponsiveness is often thought to be a hallmark of recessively inherited ABCC8 mutations. This patient was initially thought to be non-responsive, but this case highlights that a further trial of diazoxide is warranted, where other available treatments are associated with significant risk of morbidity. Learning points: Homozygous ABCC8 mutations are commonly thought to cause diazoxide non-responsive hyperinsulinaemic hypoglycaemia. This case highlights that partial diazoxide responsiveness in homozygous ABCC8 mutations may be present. Trial of diazoxide treatment in combination with octreotide is warranted prior to considering alternative treatments, such as sirolimus or near-total pancreatectomy, which are associated with more significant side effects.

Novel ABCC8 mutation in the genetic diagnosis of familial hyperinsulinaemic hypoglycaemia

Congenital Hyperinsulinism in China: A Review of Chinese Literature over the Past 15 Years

Neonatal Hyperinsulinism with an ABCC8 Mutation: A Case Report

Congenital hyperinsulinism: 2 case reports with different rare variants in ABCC8

Permanent Neonatal Diabetes Mellitus in China

Case report: Congenital hyperinsulinemia with ABCC8 gene mutations

Clinical Characteristics of Pregnancy-Associated Fulminant Type 1 Diabetes--a Single Center Experience

Genetic Heterogeneity Correlated with Phenotypic Variability

Heterozygous Insulin Receptor (INSR) Mutation Associated with Neonatal Hyperinsulinemic Hypoglycaemia and Familial Diabetes Mellitus: Case Series

Clinical and Genetic Characteristics of ABCC8 Nonneonatal Diabetes Mellitus: A Systematic Review.

A family in which people with a heterozygous ABCC8 gene mutation (p.Lys1385Gln) have progressed from hyperinsulinemic hypoglycemia to hyperglycemia

A Homozygous Exonic Variant Leading to Exon Skipping in ABCC8 As the Cause of Severe Congenital Hyperinsulinism

Case Report: Hypoglycemia Due to a Novel Activating Glucokinase Variant in an Adult – a Molecular Approach

Nesidioblastosis in Pregnancy: Navigating the Diagnostic and Therapeutic Challenges of a Rare Condition

[Congenital hyperinsulinism : contributions of chemistry, therapeutic response, genetics and imaging]

Transient diabetes mellitus with ABCC8 variant successfully treated with sulfonylurea: Two case reports and review of literature

[Clinical and genetic analysis of an infant with permanent neonatal diabetes mellitus due to novel variant of insulin gene].

Functional characterization of inactivating ABCC8 variants causing congenital hyperinsulinism

Partial diazoxide responsiveness in a neonate with hyperinsulinism due to homozygous ABCC8 mutation

ABCC8-related maturity-onset diabetes of the young: Clinical features and genetic analysis of one case

Uncovering the Molecular Pathogenesis of Congenital Hyperinsulinism by Panel Gene Sequencing in 32 Chinese Patients.